GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD. The goal of the new agreement is to develop a small-molecule-based medicine to potentially reverse FSHD
GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD
Progress in FSHD Muscular Dystrophy Research Hailed at International Meeting
San Francisco, CA / November 08, 2012 Just two decades ago, the scientific world largely ignored a mysterious disease that causes muscles to weaken throughout the body. Called fascioscapulohumeral muscular… Read More »
Get involved with research! FSHD-affected and FSHD-unaffected volunteers needed
Get involved with research! FSHD-affected and FSHD-unaffected volunteers needed for research study using (MRI) and magnetic resonance spectroscopy (MRS) imaging in skeletal muscle at KKI, Baltimore, Maryland. Learn more about… Read More »
Volunteers within driving distance of University of California, Davis needed for research study on State-of-the-art clinical endpoints.
Volunteers within driving distance of University of California, Davis needed for research study on State-of-the-art clinical endpoints. Learn more about the study, inclusion criteria and how to get involved read… Read More »
High-profile paper on FSHD published in Cell
High-profile paper on FSHD published in Cell by Drs. Davide Gabellini and Daphne Cabianca in Milan, Italy. There are three distinct messages in the paper: 1. FSH Society funding leads to… Read More »